Peer Review History
| Original SubmissionApril 24, 2024 |
|---|
|
PONE-D-24-15969An automated high-content screening and assay platform for the analysis of spheroids at subcellular resolutionPLOS ONE Dear Dr. Simpson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== The reviewers have provided a careful and thorough evaluation of your manuscript, and report a considerable list of 'minor' issues that would need to be well-addressed before the manuscript would be acceptable for publication. The reviewers seek to have a rewrite that would better define whether the manuscript is a technical report or a research report; currently it is a mix. Reviewer 1 seeks answers to multiple technical details (1-6) for the plate processing, optical imaging issues, segmentation of organelles, replicates. Reviewer 2 (1, 2a/b) seeks information on the nature of the organoids (a natural structure, or an unusual association of packed cells; explanation of the diffrences in 2D vs 3D responses?), and also if the manuscript is intended to be a technical report, further detail is requested and included in supplemental for the interested readership, followed by a list of minor issues (1-11) that should be addressible. ============================== Please submit your revised manuscript by Jul 15 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Michael A. Mancini Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following financial disclosure: "MMM is supported by the Government of Ireland Postdoctoral Fellowship from the Irish Research Council (GOIPD/2023/1135)" Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: "The authors thank all members of the lab for their input and helpful discussions. MMM is supported by the Government of Ireland Postdoctoral Fellowship from the Irish Research Council (GOIPD/2023/1135). The JCS Laboratory is supported by the UCD College of Science. " We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "MMM is supported by the Government of Ireland Postdoctoral Fellowship from the Irish Research Council (GOIPD/2023/1135)" Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. In this instance it seems there may be acceptable restrictions in place that prevent the public sharing of your minimal data. However, in line with our goal of ensuring long-term data availability to all interested researchers, PLOS’ Data Policy states that authors cannot be the sole named individuals responsible for ensuring data access (http://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-sharing-methods). Data requests to a non-author institutional point of contact, such as a data access or ethics committee, helps guarantee long term stability and availability of data. Providing interested researchers with a durable point of contact ensures data will be accessible even if an author changes email addresses, institutions, or becomes unavailable to answer requests. Before we proceed with your manuscript, please also provide non-author contact information (phone/email/hyperlink) for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If no institutional body is available to respond to requests for your minimal data, please consider if there any institutional representatives who did not collaborate in the study, and are not listed as authors on the manuscript, who would be able to hold the data and respond to external requests for data access? If so, please provide their contact information (i.e., email address). Please also provide details on how you will ensure persistent or long-term data storage and availability. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The study by Mysior and Simpson is valuable for the 3D HTM/HCA community but lacks many details that would be required to reproduce and/or scale up the approach, including the primary data. specifically, the following questions should be addressed. Plus a general answer: has the process been tested on different cell models or only in the HeLa subclone described? 1. it would be useful to have more details about the plate processing - i.e., volumes, how are the plate handled (manual, robotic) 2. were different antibody incubation times and/or triton incubation times tested? 3. it is unclear if segmentation was performed on each 2D plane and then somewhat concatenated or as true 3D segmentation. why was the cytoplasm segmented off a "non specific" hoechst signal and not GFP? 4. more details are needed to understand why and how filters were sued to segment organelles and how thresholds were chosen 5. what is a little problematic is that somehow the authors calculate (estimate?) volumes but it is not explained how and the imaging conditions described clearly show that optical section is too big to be at Nyquist, hence the volume will not be precise. also, there is no mention of the obvious z distortion and if/how it was compensated in the calculations 6. indication of replicates (technical and biological) should be clearly spelled out in the methods section 7. the statement "Single cell data could not be statistically analysed with standard statistical tests due to the high number of data values" is unacceptable as the number of single cell data values is not very high and single cell analysis is essential if the effort to segment single cells is implemented 8. what is the fraction of successful spheroid formed over total seeded? 9. in Figure 2 the scale bar seems wrong, especially when compared to the other figures Reviewer #2: In the manuscript titled “An automated high-content screening and assay platform for the analysis of spheroids at subcellular resolution” the authors present the development of a technique to generate a large number of arrayed relatively uniform spheroids using micropatterned multi-well plates. The authors describe how these samples can be imaged using an automated high-resolution image cytometer and analyzed at the spheroid-, cell-, and subcellular-level using an algorithm developed within the Harmony software platform. Finally, they demonstrate how the assay can detect changes induced by inhibitors that affect the Golgi apparatus or microtubules. The strength of the manuscript is the presented techniques address an ongoing need in the research community to efficiently generate and analyze more representative 3D samples. The key weakness is the limited characterization of the quality of generated spheroid. Although the manuscript would be significantly strengthened if this weakness was addressed, the work presented in the manuscript is well written and scientifically sound and merits publication in PLOS One. Strengths 1) The authors introduce a method to generate large numbers of relatively uniform spheroids. If proven broadly applicable, this would advance the ability to perform HTS using spheroid samples. 2) The authors demonstrate how tools within the Harmony software platform can be used to achieve sub-cellular analysis resolution. Weakness 1) It is unclear if this technique is producing quality spheroids with cells tightly interacting with each other or simply cell aggregates centered on the micropatterned ‘well’. The manuscript would be strengthened significantly if efforts were made to assess the quality of the spheroids produced by the micropattern technique. Alternatively, authors could demonstrate how responses differed in the 3D spheroid vs the 2D culture of the cell lines used in the study, which would indicate biological differences associated with the 3D samples. 2) The focus of the manuscript is somewhat unclear. 2a) It appears written primarily as a technique/assay development paper. As such, further detail on the methods/analysis algorithm used could be provided. The optimization work would be important to share in supplemental material. Importantly, it should be made clear if the Harmony algorithm will be made/are available to the research community. In addition, metrics describing assay quality (for example, Z’-prime values) should be calculated and provided. 2b) The authors devote significant space describing the importance of using 3D cultures/spheroids to generate more representative samples to study cell physiology compared to 2D cultures, however, no data was presented to suggest the current assay captures that difference. The advantage of 3D spheroids are intended to be the focus of the manuscript, comparative data with 2D cultures should be included. Other Comments 1. Line 73 – Missing punctuation/incomplete sentence 2. Line 165 – Methods list several objectives used, but it is unclear in the manuscript where each (if all) were used. 3. Line 166 – Typo “63x/1.1.15NA”. 4. Line 189 – More accurate to state that statistical analysis of single cell data is not presented due to the large number of samples generating significant differences with limited/unclear biological meaning. 5. Line 206-207 – As an assay development paper, it might be useful to describe the optimization process in greater detail for others attempting similar assays using alternative cell types. 6. Figure 1 Legend – Would be good to indicate if displayed image represents a single field or a stitched collection of fields. 7. Line 344-345 – For readers not familiar with the Harmony software, it would be good to provide the type of texture being measured by the ‘plane bright’ and ‘saddle’ texture components. 8. The authors should comment about any issues with photobleaching when collecting a large z-stack at 100% laser power and image exposure times up to 500 msec. 9. It would be informative if authors provided an average scanning time per plate/per well to collect the low and high resolution images. 10. A key limitation of high NA objectives is a limited working depth. While this did not impact the current study due to relatively small spheroids generated using the microprinting technique, it would be good if the authors commented on how this might impact broader application of the methods to other types of 11. Scale Bar length vs spheroid shown in figures. Figure 1D indicates an average spheroid width ranging between ~80-90 um. However, at a scale bar length of 50 um, it appears many of the spheroids shown at higher resolution in figures are approaching ~150 um width, falling within in the far extreme range observed at 20X. Confirm that scale bar length is correct, or it would be good to state in the text/figure legend that especially large spheroids were chosen to allow easier visualization of the phenotype/masking. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Adam T. Szafran ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-24-15969R1An automated high-content screening and assay platform for the analysis of spheroids at subcellular resolutionPLOS ONE Dear Dr. Simpson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 24 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Michael A. Mancini Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear authors: The manuscript has been markedly improved. I expect that the minor, but the very useful concerns of Reviewer 2 would be straightforward to respond to, which would result in the manuscript becoming acceptable. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: we thank the authors for addressing all the points that were discussed. the manuscript now contains all the information needed for publication Reviewer #2: With the revisions and added technical details, the authors have address the primary weakness and clearly made the paper focused on the technical protocol for analyzing the 3D spheroids. The previous strengths remain. The manuscript is suitable for publication in PLOS One with some minor revisions. Minor Comments: [Line 189] The authors state spheroids were segmented using the A647 secondary antibody signal. For any significant screening project, the use of antibodies would significantly increase the cost per well. Therefore, it would be beneficial if the authors could comment if similar spheroid region segmentation is possible using either the DNA dye or GFP signal (when present). [General comment] The authors describe the developed tools as useful for screening, however, more effort could be made to describe how much variation observed between replicate samples. For example, well-to-well variation in the average number of detected objects per cell or per spheroid. [Line 282] The use of the phrase "a high degree of accuracy" suggests the use of a metric that quantifies segmentation quality compared to an annotated ground truth set of images (i.e. IoU, F1, etc analysis). If no such comparison was performed. it may be better to make a statement stating that the assessment of accuracy was qualitative and not quantitative. [General Comment] Charts appear low resolution in the PDF. This is not an issue with the supplemental figures. [General Comment] Instances where the authors' description of the data does not match what the figure shows. For example, authors describe figure 5A data (line 367) as 'no detectable difference in the number of structures', yet, the figure indicates a significant difference. This is a carry-over of the revision now containing the statistical analysis of single-cell data, but the language used need to be corrected. [Line 732] The figure legend does not indicate the meaning of the colors used. Are the individual objects pseudo-colored? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Adam T. Szafran, MD/PhD ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
An automated high-content screening and assay platform for the analysis of spheroids at subcellular resolution PONE-D-24-15969R2 Dear Dr. Simpson, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Michael A. Mancini Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-15969R2 PLOS ONE Dear Dr. Simpson, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Michael A. Mancini Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .